Each member of the team at Genesys Capital brings significant knowledge and expertise in the high technology and biotechnology sectors.
- Kelly Holman, Managing Director
- Damian Lamb, Managing Director
- Jamie Stiff, Partner
- Jennifer Williams, Director of Finance and Operations
Kelly Holman | Co-Founder and Managing Director
Mr. Holman is co-Founder and Managing Director of Genesys Capital and has extensive commercial and technical experience in the biotechnology industry. Since co-founding Genesys Capital in 2000, Mr. Holman has been actively involved in raising over $225 million of venture capital and has been instrumental in deploying over $140 million across 28 investments. He currently serves on the Board of Directors of Functional Neuromodulation Ltd. and ImpoPharma Inc. From 2001 to 2013, he served on the board of Epocal, a Genesys portfolio company recently acquired by Alere (NYSE: ALR). Mr. Holman is active in deal origination and company creation and has advised Canada's National Biotechnology Advisory Committee on strategies for financing start-up and early-stage biotechnology companies.
Prior to co-founding Genesys Capital, Mr. Holman was a Senior Investment Manager with MDS Capital Corp. During his tenure at MDS, he was involved in all stages of investment from start-up and early-stage to mezzanine stage and public company investing.
Previously, Mr. Holman worked in the laboratory of Dr. Peter St George-Hyslop at the University of Toronto where he was a key member of the international research team that discovered several genes responsible for Alzheimer's disease. Mr. Holman holds a Bachelor of Science (Honours) in Biochemistry and an MBA, both from Queen's University.
Damian Lamb | Co-Founder and Managing Director
Mr. Lamb is co-Founder and Managing Director of Genesys Capital. He brings a unique experience base, blending skills in both the commercial and technical side of biotechnology. Since co-founding Genesys Capital in 2000, Mr. Lamb has been instrumental in raising over $225 million in venture capital funds, and has been involved in deploying over $140 million in 28 investments. He currently serves on the Boards of Affinium Pharmaceuticals Inc., Profound Medical Inc. and the Centre for Probe Development and Commercialization at McMaster University. He has served on the Board of Ionalytics Corporation (acquired by Thermo Electron Corp.), Millenium Biologix (acquired by Medtronic) and was Chairman of the Board of DELEX Therapeutics Inc. when it was sold to YM BioSciences. Mr. Lamb works closely with Genesys investee companies to strategically position the companies to build value for shareholders.
Prior to co-founding Genesys Capital, Mr. Lamb was an Investment Manager with MDS Capital Corp. He is a frequently invited speaker at biotechnology industry conferences and was a judge for the BioNorth Top 10 Canadian Life Sciences Companies contest from 2000 to 2008.
Mr. Lamb graduated from McMaster University, Faculty of Health Sciences, with an M.S. in Molecular Neurobiology and also holds an MBA from Queen's University.
Jamie Stiff | Partner
Mr. Stiff joined Genesys Capital in 2002 and became partner at the firm in 2007. Over his tenure with Genesys, he has been responsible for investments in nine early stage/start-up portfolio companies that cross a multitude of clinical disciplines and technology areas.
Mr. Stiff currently serves on the boards of gIcare Pharma Inc., Therapeutic Monitoring Systems Inc., Naurex Inc. and NeurAxon Inc. in various capacities. Past board affiliations include Allostera Pharma Inc., Matregen Corp, StemPath Inc., Zelos Therapeutics, Inc. and Interface Biologics, Inc.
Prior to joining Genesys, Mr. Stiff worked at the Samuel Lunenfield Research Institute at Mount Sinai Hospital in the genetic diagnostics arena. This experience, combined with an academic background in biology, has provided significant technical knowledge of many areas of life sciences. Mr. Stiff completed a Bachelor of Science (Honours) from Queen's University and an MBA from the Rotman School of Management.
Jennifer Williams | Director of Finance and Operations
Ms. Williams is Director of Finance and Operations and joined Genesys Capital in 2002. Ms. Williams brings to Genesys a well-balanced range of skills. She has a proven track record of success in implementing a variety of major projects, and in working with senior stakeholders and key contacts. During her career with Genesys she has worked closely with the team to develop the operations and is responsible for finance and administration.
Ms. Williams graduated from the University of Guelph with a Bachelor of Commerce (Honours) and holds an MBA from Queen's University.